Articles

Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells

Division of Hematology and Oncology, Department of Medicine, Freiburg University Medical Center, Albert-Ludwigs-University, Freiburg, Germany;Faculty of Biology, Albert-Ludwigs-University, Freiburg, Germany
Division of Hematology and Oncology, Department of Medicine, Freiburg University Medical Center, Albert-Ludwigs-University, Freiburg, Germany
Division of Hematology and Oncology, Department of Medicine, Freiburg University Medical Center, Albert-Ludwigs-University, Freiburg, Germany;Faculty of Biology, Albert-Ludwigs-University, Freiburg, Germany
Division of Hematology and Oncology, Department of Medicine, Freiburg University Medical Center, Albert-Ludwigs-University, Freiburg, Germany;Faculty of Biology, Albert-Ludwigs-University, Freiburg, Germany
Division of Hematology and Oncology, Department of Medicine, Freiburg University Medical Center, Albert-Ludwigs-University, Freiburg, Germany
Division of Hematology and Oncology, Department of Medicine, Freiburg University Medical Center, Albert-Ludwigs-University, Freiburg, Germany
Department of Pathology, Freiburg University Medical Center, Albert-Ludwigs-University, Freiburg, Germany
Institute of Medical Microbiology and Hygiene, Department of Immunology, University of Freiburg, Germany
Department of Pathology, Freiburg University Medical Center, Albert-Ludwigs-University, Freiburg, Germany
Division of Hematology and Oncology, Department of Medicine, Freiburg University Medical Center, Albert-Ludwigs-University, Freiburg, Germany
Institute of Medical Microbiology and Hygiene, Department of Immunology, University of Freiburg, Germany
Division of Hematology and Oncology, Department of Medicine, Freiburg University Medical Center, Albert-Ludwigs-University, Freiburg, Germany;BIOSS Centre for Biological Signaling Studies, Freiburg, Germany
Vol. 98 No. 1 (2013): January, 2013 https://doi.org/10.3324/haematol.2012.065789